NCGC00092410

Research use only, not for human use.

NCGC00092410 (ML008) is a glucocerebrosidase (GC) inhibitor with IC50 value of 31 nM. It can be used for the study of Gaucher disease caused by mutation of glucocerebrase gene.

NCGC00092410 is a potent, selective, and nonsugar glucocerebrosidase (GC) inhibitor, with an IC50 of 31 nM. NCGC00092410 shows no activity against the related hydrolases at concentrations up to 77 μM. NCGC00092410, a GC chaperone, and increases the activity and lysosomal localization of glucocerebrosidase in mutant cell lines. NCGC00092410 can be used for the research of Gaucher disease.

NCGC00092410 (7.3-130 nM; 25 min) inhibits the GC activity at various substrate concentrations (10-150 μM) in a dose-dependent manner.NCGC00092410 (55-40 μM; 2 d) increases the GC activity in the N370S mutant fibroblasts.NCGC00092410 (40 μM; 60-72 h) increases the lysosomal localization of GC in gaucher fibroblasts.

——

——

Others

Other Targets

Glucosidase

——

——

442898-34-2

353.46

C21H27N3O2

>98% (HPLC)

In Vitro:?DMSO : 41.67 mg/mL (117.89 mM; Ultrasonic )

Cc1cc(nc2ccc(NC(=O)C3CCCCC3)cc12)N1CCOCC1

——

(-20℃)

With Ice Pack

≥ 2 years